Michèle Lonergan

3.2k total citations
26 papers, 2.3k citations indexed

About

Michèle Lonergan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Social Psychology. According to data from OpenAlex, Michèle Lonergan has authored 26 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 18 papers in Pulmonary and Respiratory Medicine and 6 papers in Social Psychology. Recurrent topics in Michèle Lonergan's work include Ion Transport and Channel Regulation (17 papers), Electrolyte and hormonal disorders (16 papers) and Ion channel regulation and function (6 papers). Michèle Lonergan is often cited by papers focused on Ion Transport and Channel Regulation (17 papers), Electrolyte and hormonal disorders (16 papers) and Ion channel regulation and function (6 papers). Michèle Lonergan collaborates with scholars based in Canada, United States and France. Michèle Lonergan's co-authors include Daniel G. Bichet, Marie‐Françoise Arthus, Michel Bouvier, Virginie Bernier, André Laperrière, Ali Salahpour, Jean-Pierre Morello, Walter Rosenthal, Ulla E. Petäjä‐Repo and Geoffrey N. Hendy and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Clinical Investigation.

In The Last Decade

Michèle Lonergan

26 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michèle Lonergan Canada	20	1.9k	1.2k	436	231	219	26	2.3k
Marie‐Françoise Arthus Canada	19	1.7k 0.9×	1.1k 0.9×	375 0.9×	209 0.9×	197 0.9×	31	2.1k
Danièlle Chabardès France	24	1.1k 0.6×	489 0.4×	253 0.6×	184 0.8×	154 0.7×	41	1.7k
Marina Zelenina Sweden	18	1.3k 0.7×	636 0.5×	101 0.2×	100 0.4×	195 0.9×	34	1.7k
M. Wittner France	24	1.2k 0.6×	394 0.3×	82 0.2×	241 1.0×	292 1.3×	51	2.1k
Mouhamed S. Awayda United States	21	1.1k 0.6×	370 0.3×	69 0.2×	120 0.5×	178 0.8×	42	1.4k
Russell F. Husted United States	22	1.0k 0.5×	415 0.4×	33 0.1×	166 0.7×	110 0.5×	41	1.4k
John Pizzonia United States	15	729 0.4×	169 0.1×	91 0.2×	82 0.4×	98 0.4×	24	1.2k
Ahmed Chraïbi Canada	17	915 0.5×	365 0.3×	60 0.1×	142 0.6×	152 0.7×	21	1.3k
Takaaki Yoshimasa Japan	23	988 0.5×	189 0.2×	73 0.2×	52 0.2×	547 2.5×	53	2.1k
Barry E. Argent United Kingdom	27	1.2k 0.6×	804 0.7×	25 0.1×	106 0.5×	335 1.5×	56	2.0k

Countries citing papers authored by Michèle Lonergan

Since Specialization

Citations

This map shows the geographic impact of Michèle Lonergan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michèle Lonergan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michèle Lonergan more than expected).

Fields of papers citing papers by Michèle Lonergan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michèle Lonergan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michèle Lonergan. The network helps show where Michèle Lonergan may publish in the future.

Co-authorship network of co-authors of Michèle Lonergan

This figure shows the co-authorship network connecting the top 25 collaborators of Michèle Lonergan. A scholar is included among the top collaborators of Michèle Lonergan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michèle Lonergan. Michèle Lonergan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bichet, Daniel G., Yves A. Lussier, Marie‐Françoise Arthus, et al.. (2012). Aquaporin-2: new mutations responsible for autosomal-recessive nephrogenic diabetes insipidus--update and epidemiology. Clinical Kidney Journal. 5(3). 195–202. 20 indexed citations

Lussier, Yves A., Marie‐Françoise Arthus, Michèle Lonergan, et al.. (2010). New autosomal recessive mutations in aquaporin‐2 causing nephrogenic diabetes insipidus through deficient targeting display normal expression in Xenopus oocytes. The Journal of Physiology. 588(12). 2205–2218. 15 indexed citations

Bissonnette, Pierre, Michèle Lonergan, Marie‐Françoise Arthus, et al.. (2009). Characterization of D150E and G196D aquaporin-2 mutations responsible for nephrogenic diabetes insipidus: importance of a mild phenotype. American Journal of Physiology-Renal Physiology. 297(2). F489–F498. 18 indexed citations

Bernier, Virginie, Jean-Pierre Morello, Ali Salahpour, et al.. (2005). Pharmacologic Chaperones as a Potential Treatment for X-Linked Nephrogenic Diabetes Insipidus. Journal of the American Society of Nephrology. 17(1). 232–243. 171 indexed citations

Bernier, Virginie, Monique Lagacé, Michèle Lonergan, et al.. (2004). Functional Rescue of the Constitutively Internalized V2 Vasopressin Receptor Mutant R137H by the Pharmacological Chaperone Action of SR49059. Molecular Endocrinology. 18(8). 2074–2084. 114 indexed citations

Mattia, Fabrizio De, Paul J.M. Savelkoul, Daniel G. Bichet, et al.. (2004). A novel mechanism in recessive nephrogenic diabetes insipidus: wild-type aquaporin-2 rescues the apical membrane expression of intracellularly retained AQP2-P262L. Human Molecular Genetics. 13(24). 3045–3056. 42 indexed citations

Lonergan, Michèle, K.W. Marvin, Rachel J. A. Helliwell, et al.. (2003). Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL), TRAIL Receptors, and the Soluble Receptor Osteoprotegerin in Human Gestational Membranes and Amniotic Fluid during Pregnancy and Labor at Term and Preterm. The Journal of Clinical Endocrinology & Metabolism. 88(8). 3835–3844. 55 indexed citations

Marr, Nannette, Daniel G. Bichet, Paul J.M. Savelkoul, et al.. (2002). Cell-Biologic and Functional Analyses of Five New Aquaporin-2 Missense Mutations that Cause Recessive Nephrogenic Diabetes Insipidus. Journal of the American Society of Nephrology. 13(9). 2267–2277. 89 indexed citations

Kuwahara, Michio, Kazuyuki Iwai, Takashi Igarashi, et al.. (2001). Three Families with Autosomal Dominant Nephrogenic Diabetes Insipidus Caused by Aquaporin-2 Mutations in the C-Terminus. The American Journal of Human Genetics. 69(4). 738–748. 109 indexed citations

10.

Morello, Jean-Pierre, Ali Salahpour, André Laperrière, et al.. (2000). Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. Journal of Clinical Investigation. 105(7). 887–895. 462 indexed citations

11.

Mulders, S.M., Daniel G. Bichet, J.P.L. Rijss, et al.. (1998). An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex.. Journal of Clinical Investigation. 102(1). 57–66. 195 indexed citations

12.

Rosenthal, Walter, Anita Seibold, Anaid Antaramián, et al.. (1994). Mutations in the vasopressin V2 receptor gene in families with nephrogenic diabetes insipidus and functional expression of the Q-2 mutant.. PubMed. 40(3). 429–36. 30 indexed citations

13.

Bichet, Daniel G., Mariel Birnbaumer, Michèle Lonergan, et al.. (1994). Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus.. PubMed. 55(2). 278–86. 112 indexed citations

14.

Bichet, Daniel G., Marie‐Françoise Arthus, Michèle Lonergan, et al.. (1993). X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis.. Journal of Clinical Investigation. 92(3). 1262–1268. 110 indexed citations

15.

Bichet, Daniel G., Geoffrey N. Hendy, Michèle Lonergan, et al.. (1992). X-linked nephrogenic diabetes insipidus: from the ship Hopewell to RFLP studies.. PubMed. 51(5). 1089–1102. 36 indexed citations

16.

Rosenthal, Walter, Anita Seibold, Anaid Antaramián, et al.. (1992). Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus. Nature. 359(6392). 233–235. 231 indexed citations

17.

Kinter, Lewis B., S. Campbell, William F. Huffman, et al.. (1992). Vasopressin antagonist inhibition of clotting factor release in the rhesus monkey (Macaca mulatta).. Journal of Pharmacology and Experimental Therapeutics. 261(2). 462–469. 8 indexed citations

18.

Lonergan, Michèle & Michael Field. (1991). RENAL SODIUM EXCRETION FOLLOWING SYSTEMIC INFUSION OF VASOACTIVE INTESTINAL PEPTIDE IN THE RAT. Clinical and Experimental Pharmacology and Physiology. 18(12). 819–824. 1 indexed citations

19.

Bichet, Daniel G., Mohammad Hossein Razi, Marie‐Françoise Arthus, et al.. (1989). Epinephrine and dDAVP administration in patients with congenital nephrogenic diabetes insipidus. Kidney International. 36(5). 859–866. 59 indexed citations

20.

Bichet, Daniel G., et al.. (1988). Hemodynamic and Coagulation Responses to 1-Desamino[8-D-Arginine] Vasopressin in Patients with Congenital Nephrogenic Diabetes Insipidus. New England Journal of Medicine. 318(14). 881–887. 168 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact